J, Romero D, Sabin C, Serwadda D, Waters L. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nat Commun 2021 Jul 16;12(1):4450 Barros-Martins [...] Schlue J, Bedossa P, Capeau J, Costagliola D, Behrens GMN*, Ingiliz P*, on behalf of the ANRS-ECHAM group. Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter [...] a A, Jäck H-M*, Behrens GMN*, Pöhlmann S*. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic. Cell 2022, 184: 1-10. (*equal

Rehabilitation services for closing the rehabilitative gap after major amputation of lower extremity. Congress of European Forum of Research in Rehabilitation 2021; Book of Abstracts with Programm, S. 46 Sturm [...] er C, Krauss JK, Stangel M, Höglinger GU, Wallesch CW, Rollnik JD. The influence of the CRS-R score on functional outcome in patients with severe brain injury receiving early rehabilitation. BMC Neurol [...] Syndrome Patients. Front Neurosci 2021; DOI: https://doi.org/10.3389/fnins.2021.554194 Camden C, Mulligan H, Nugraha B, Jade Berbari J, Gauvin C, Cinar E, Gutenbrunner C,The scope and practices of physical

Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy. PLoS One 2017; 12(7): e0181107 Dommaschk A, Ding [...] Schipper E, Kreipe H, Lehmann U: Molecular Analysis of Circulating Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation [...] cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial. Ann Hematol 2017; 96(6): 887-894 Bräsen JH , Khalifa

RK. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome. Leukemia. 2019; 33(7): 1759-1772 Rubio K, Singh I [...] C, Wenz F, Witzel I, Wöckel A. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. Breast Care (Basel). 2019; 14(4): 224-245 Dubich T, Lieske A, Santag [...] line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo. J Mol Med (Berl). 2019; 97(3):

PMID: 35619694 Free PMC article. The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C. de Gregorio [...] analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology [...] 10.1148/radiol.221145. Online ahead of print. PMID: 36537894 Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Verstockt

management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric [...] management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric [...] Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group

Hessler K., Claus P., Zechel K. Structural and functional consequences of mutations within the hydrophobic cores of the HMG1-box domain of the insect protein cHMG1a. Eur. J. Biochem. 243: 151-159, 1997 Wewetzer [...] Wisniewski J.R. Conformational changes of DNA induced by binding of Chironomus high mobility group protein 1a: regions flanking an HMG-box domain do not influence the bend angle of the DNA. J. Biol. Chem. 272: [...] component of spinal muscular atrophy. Annals of Clinical and Translational Neurology 6:1519-1532. Gamze Bora, Caren Sucularli, Niko Hensel, Peter Claus, Hayat Erdem Yurter (2019): Investigations of Microt

Ruutu T, Basak GW. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT. Bone Marrow [...] short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med. 2018 Sep;44(9):1483-1492 [...] Morris C, Gahrton G. Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing

Kaisenberg C, Keck J, Stripecke R. “In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution” Biomedicines . 2021 Aug 5;9(8):961 [...] Schambach A, Lachmann N, Wirth D, Moritz T. “The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function.” Sci Rep. 2017 Aug 11 [...] Padiatr . 2024 Jan 29. https://doi.org/10.1055/a-2233-1243 Paasch D, Lachmann N , “CAR macrophages tuning the immune symphony of anti-cancer therapies” Cell Stem Cell. 2024 DOI: https://doi.org/10.1016/j.stem

M; Neurooncology Working Group (NOA) of the German Cancer Society.. Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide [...] K, Michiels S, Loi S, Salgado R: Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Mod [...] dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS